GRK2 negatively regulates glycogen synthesis in mouse liver FL83B cells

Area of Science:

• Biochemistry
• Cell Biology
• Endocrinology

Background:

• G-protein-coupled receptor kinases (GRKs) typically desensitize G-protein-coupled receptors.
• The insulin receptor (IR), a tyrosine kinase receptor, also interacts with G-protein signaling pathways.
• The role of GRK2 in regulating IR signaling remains largely unexplored.

Purpose of the Study:

• To investigate the hypothesis that GRK2 negatively regulates insulin receptor (IR) signaling.
• To elucidate the mechanism by which GRK2 impacts IR function and downstream signaling pathways.

Main Methods:

• Utilized FL83B mouse liver cells treated with insulin.
• Assessed GRK2 membrane translocation via immunofluorescence and Western blotting.
• Down-regulated GRK2 expression using small interfering RNA (siRNA).
• Measured glycogen synthesis via d-[U-(14)C]glucose incorporation.
• Analyzed protein phosphorylation (IR, IR substrate 1, glycogen synthase kinase-3alpha) using Western blotting.

Main Results:

• Insulin induced GRK2 translocation to the plasma membrane.
• GRK2 deficiency significantly increased basal and insulin-stimulated glycogen synthesis.
• GRK2 knockdown enhanced phosphorylation of IR substrate 1 (Tyr612) and glycogen synthase kinase-3alpha (Ser21), while decreasing Ser307 phosphorylation.
• Chronic insulin treatment led to decreased IR expression and impaired function in control cells, but not in GRK2-deficient cells.
• GRK2 negatively regulates IR signaling post-receptor level.

Conclusions:

• GRK2 acts as a negative regulator of insulin receptor signaling, impacting glycogen synthesis.
• GRK2 deficiency improves insulin sensitivity and protects against IR dysfunction induced by chronic insulin exposure.
• Targeting GRK2 may offer a therapeutic strategy for improving insulin sensitivity in metabolic disorders.